Skip to content
ppharmaranks
Menu

Best treatments for amyotrophic lateral sclerosis

3 products may treat amyotrophic lateral sclerosis, spanning FDA drug classes such as benzothiazole. The current highest-rated option is qalsody. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for amyotrophic lateral sclerosis, 1 is available as lower-cost generics, spanning classes such as benzothiazole. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for amyotrophic lateral sclerosis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Top-rated picks for amyotrophic lateral sclerosis: 1. Qalsody · 2. Radicava Ors · 3. Tiglutik Kit

Top-rated treatments for amyotrophic lateral sclerosis, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100View →
270/100View →
3Not yet rated$9View →

Full ranking · 3 treatments

Frequently asked

What treats amyotrophic lateral sclerosis?
Our catalog lists 3 products that may treat amyotrophic lateral sclerosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is qalsody.
What is the best-rated treatment for amyotrophic lateral sclerosis?
By our independent recall-safety rating — not an efficacy measure — qalsody ranks highest among the products we list for amyotrophic lateral sclerosis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat amyotrophic lateral sclerosis?
Treatments for amyotrophic lateral sclerosis span FDA drug classes including benzothiazole. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.